Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | potassium voltage gated channel subfamily A | 0.0159 | 0.942 | 0.8604 |
Schistosoma mansoni | hypothetical protein | 0.0114 | 0.5843 | 0.5843 |
Echinococcus granulosus | potassium voltage gated channel subfamily A | 0.0166 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.0823 | 0.0823 |
Trypanosoma cruzi | ion transport protein, putative | 0.0097 | 0.4442 | 0.5 |
Leishmania major | ion transport protein-like protein | 0.0097 | 0.4442 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0057 | 0.1292 | 0.1292 |
Loa Loa (eye worm) | hypothetical protein | 0.0114 | 0.5843 | 0.5843 |
Trypanosoma cruzi | ion transport protein, putative | 0.0097 | 0.4442 | 0.5 |
Schistosoma mansoni | calcium-activated potassium channel | 0.0114 | 0.5843 | 0.5843 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.152 | 0.152 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.152 | 0.152 |
Echinococcus multilocularis | potassium voltage gated channel protein | 0.0166 | 1 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.152 | 0.152 |
Echinococcus granulosus | potassium voltage gated channel protein | 0.0166 | 1 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.152 | 0.152 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0166 | 1 | 1 |
Schistosoma mansoni | calcium-activated potassium channel | 0.0109 | 0.5398 | 0.5398 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0166 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0166 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 3.5481 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | 39.8107 uM | PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 75.193 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | = 100 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.